Detection And Classification of Acute Lymphoblastic Leukemia using CNN A Comprehensive Approach to Early Detection and Accurate Classification Using ResNet50
Main Article Content
Abstract
Acute lymphoblastic leukemia is a very important cancer in childhood but quite prominent in later years of life for the genetic defects in lymphoid progenitors, which are hallmarks of the disease. In children, ALL mostly affects those aged between 2 and 6 years old and, against the background of contemporary biology knowledge and treatment approaches, is associated with more than 80% cure rates. However, approximately 20% of children with ALL relapse; therefore, there is a huge need for better risk identification and treatment optimization. In adults, ALL mainly affects B-cell precursors and is treated with chemotherapy and, in some cases, stem cell transplantation.
An accurate and early diagnosis of ALL is of key importance but difficult to realize due to morphological similarities between normal cells and leukemic cells. This study, therefore, proposes a CNN model to improve diagnostic accuracy. Furthermore, it exploits the capabilities of CNN in feature extraction with Adamax Optimizer and the Categorical Cross-Entropy Loss Function to deal with imbalances and noise in the dataset. RESNET50-CNN has achieved 98.63% accuracy in classification and is hence a very strong tool in ALL detection and classification.
Keywords: Acute Lymphoblastic Leukemia, ALL, Convolutional Neural Network, CNN, RESNET50, Adamax, diagnosis, pediatric oncological chemotherapy.
Downloads
Article Details
COPYRIGHT
Submission of a manuscript implies: that the work described has not been published before, that it is not under consideration for publication elsewhere; that if and when the manuscript is accepted for publication, the authors agree to automatic transfer of the copyright to the publisher.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
- The journal allows the author(s) to retain publishing rights without restrictions.
- The journal allows the author(s) to hold the copyright without restrictions.